You are here: Industry Insights > Drug rebates

News List

US Senate invites pharmacy benefit managers to testify on drug pricing pharmaceutical-technology
March 14, 2019
The US Senate Finance Committee has invited executives from five major pharmacy benefit managers (PBMs) to testify about the rising prescription medicine costs in the country.
Pharma CEOs enthuse about Trump's plan to shake up drug rebates fiercepharma
February 24, 2019
Sweep out drug rebates for patient discounts instead? Big Pharma CEOs are all over it.
UnitedHealthcare demands drug rebates even if pharma cuts list prices fiercepharma
February 24, 2019
If drugmakers think they can save on rebates if they cut list prices as politicians and public opinion are demanding—well, forget it, says UnitedHealthcare, which sent new demands to pharma companies, an analyst wrote.
Johnson & Johnson chief figures Amazon could shake up pharma's distribution, rebates and more fiercepharma
December 12, 2018
There’s been plenty of speculation about Amazon's intentions in pharmaceuticals, and now Johnson & Johnson’s CEO has weighed in on how the tech giant could affect drug markets by shaking up pharma distribution and reimbursement.
Taking aim at Medicaid misclassifications like Mylan's EpiPen, senators look to end a 'pharma ripoff' fiercepharma
December 06, 2018
Amid Mylan’s EpiPen pricing firestorm in 2016 and 2017, the company came under fire for misclassifying the lifesaving injector as a generic on Medicaid, allowing it to drastically underpay rebates.
Want to help patients? Get rid of drug rebates, HHS chief says fiercepharma
June 14, 2018
Drug rebates and list prices have been on a race to the top, and patients have paid the price.